Abstracts - faqs.org

Abstracts

Pharmaceuticals and cosmetics industries

Search abstracts:
Abstracts » Pharmaceuticals and cosmetics industries

Release, metabolism and interconversion of adenine and uridine nucleotides: implications for G protein-coupled P2 receptor agonist selectivity

Article Abstract:

Coding sequences for numerous adenosine nucleotide-activated receptors have recently been identified which lends support to the reputation of ATP and ADP as extracellular signalling molecules. Extracellular uridine nucleotides subserve physiologically important roles given the high selectivity of several of the cloned P2Y receptors for UTP or UDP. The molecular cloning of DNA encoding P2 receptors has led to the delineation of the pharmacological selectivity of P2 receptors of defined amino acid sequence. Individual P2 receptors of known sequence and activity can soon be linked with well-defined physiological responses to extracellular nucleotides.

Author: Lazarowski, Eduardo R., Boucher, Richard C., Harden, T. Kendall
Publisher: Elsevier Science Publishers
Publication Name: Trends in Pharmacological Sciences
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0165-6147
Year: 1997
Nucleotides, Adenylic acid, Adenosine monophosphate

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Protease-activated receptors: PAR4 and counting: how long is the course?

Article Abstract:

Cloning has resulted in the creation of four protease-activated receptor (PAR). All four cloned members of the G protein-coupled receptor family have distinct protease-revealed tethered ligands and can be coupled to both G (sub q) and G (sub i). Also, results of northern blot and PCR analysis show that although they have a wide distribution of mRNA, differences exist with regards to their sites of expression. Such differences explain why PAR4 mRNA is low or absent in kidney and PAR 2 mRNA is absent in the brain and in platelets.

Author: Hollenberg, Morley D.
Publisher: Elsevier Science Publishers
Publication Name: Trends in Pharmacological Sciences
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0165-6147
Year: 1999
Proteases

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


P2 purinoceptor-mediated second messenger responses

Article Abstract:

G-protein coupled P2 purinoceptor second messenger responses have been observed in intracellular Ca2+, protein kinase C, adenylate cyclase and mitogenic pathways. Studies indicate that G protein-coupled stimulation of mitogen-activated protein kinase (MARK) is independent of phospholipasee C (PLC). An interesting theory is that PLC-independent processes may have a role in P2 purinoceptor-activattion of MARK.

Publisher: Elsevier Science Publishers
Publication Name: Trends in Pharmacological Sciences
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0165-6147
Year: 1995
G proteins, Second messengers (Biochemistry), Second messengers (Cytochemistry)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Research, Cell receptors
Similar abstracts:
  • Abstracts: Reverse intrinsic activity of antagonists on G protein-coupled receptors. Melatonin receptors step into the light: cloning and classification of subtypes
  • Abstracts: Adenosine and ATP: progress in their receptors' structures and functions. ATP-binding cassette proteins as targets for drug discovery
  • Abstracts: Neurotrophins and depression. Gamma-hydroxybutyric acid: an endogenous neuromodulator with abuse potential? Regulation of brain neurotrophin expression by physiological activity
  • Abstracts: Anti-HIV-1 protostane triterpenes and digeranylbenzophenone from trunk bark and stems of Garcinia speciosa. Anticomplement and antioxidant activities of new acetylated flavonoid glycosides from Centaurium spicatum
  • Abstracts: Pharmacological inhibition of restenosis: learning from experience. PET: a symposium highlighting its clinical and pharmacological potential
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.